0.015069 0.008700 0.000000 0.000000 0.017401 0.000000 0.000000 0.000000 0.012480 0.00000 0.00000 0.00000 Mace, J.E. Agard, D.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 6 90.00 90.00 120.00 66.360 66.360 80.130 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C2 H8 B N O2 88.901 n ALANINE BORONIC ACID peptide-like C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H8 O4 132.115 SUCCINIC ACID MONOMETHYL ESTER non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking O4 S -2 96.063 SULFATE ION non-polymer C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 254 720 736 10.1006/jmbi.1995.0650 7500345 Kinetic and structural characterization of mutations of glycine 216 in alpha-lytic protease: a new target for engineering substrate specificity. 1995 US Biochemistry BICHAW 0033 0006-2960 30 10388 Structural Basis for Broad Specificity in Alpha-Lytic Protease 1991 UK Nature NATUAS 0006 0028-0836 339 191 Structural Plasticity Broadens the Specificity of an Engineered Protease 1989 US Biochemistry BICHAW 0033 0006-2960 28 7600 Structural Analysis of Specificity: Alpha-Lytic Protease Complexes with Analogues of Reaction Intermediates 1989 US Biochemistry BICHAW 0033 0006-2960 27 7609 Serine Protease Mechanism: Structure of an Inhibitory Complex of Alpha-Lytic Protease and a Tightly Bound Peptide Boronic Acid 1987 UK J.Mol.Biol. JMOBAK 0070 0022-2836 184 479 Refined Structure of Alpha-Lytic Protease at 1.7 Angstroms Resolution. Analysis of Hydrogen Bonding and Solvent Structure 1985 UK J.Mol.Biol. JMOBAK 0070 0022-2836 131 743 Molecular Structure of the Alpha-Lytic Protease from Myxobacter 495 at 2.8 Angstroms Resolution 1979 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 DIFFRACTOMETER 1991-08-05 RIGAKU AFC-6R M x-ray 1 1.5418 1.0 1.5418 19815.014 ALPHA-LYTIC PROTEASE 3.4.21.12 M190A 1 man polymer 442.271 METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID INHIBITOR 1 syn polymer 96.063 SULFATE ION 2 syn non-polymer 18.015 water 139 nat water no no ANIVGGIEYSINNASLCSVGFSVTRGATKGFVTAGHCGTVNATARIGGAVVGTFAARVFPGNDRAWVSLTSAQTLLPRVA NGSSFVTVRGSTEAAVGAAVCRSGRTTGYQCGTITAKNVTANYAEGAVRGLTQGNACAGRGDSGGSWITSAGQAQGVMSG GNVQSNGNNCGIPASQRSSLFERLQPILSQYGLSLVTG ANIVGGIEYSINNASLCSVGFSVTRGATKGFVTAGHCGTVNATARIGGAVVGTFAARVFPGNDRAWVSLTSAQTLLPRVA NGSSFVTVRGSTEAAVGAAVCRSGRTTGYQCGTITAKNVTANYAEGAVRGLTQGNACAGRGDSGGSWITSAGQAQGVMSG GNVQSNGNNCGIPASQRSSLFERLQPILSQYGLSLVTG A polypeptide(L) no yes (MSU)AAP(B2A) XAAPA P polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Lysobacter 495 Escherichia sample 29487 ALPHA-LYTIC PROTEASE PREPROENZ 69 Lysobacter enzymogenes ALPHA-LYTIC PROTEASE PREPROENZYME 562 Escherichia coli PALP12 (PBR322-DERIVATIVE) 2.51 51.07 repository Initial release Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Version format compliance Other 1 0 1996-01-29 1 1 2008-03-24 1 2 2011-07-13 1 3 2012-12-12 1996-01-29 SPRSDE Y 1995-09-06 REL REL SO4 SULFATE ION HOH water INHIBITORY PEPTIDE BORONIC ACIDS ARE PEPTIDE ANALOGS IN WHICH THE C-TERMINAL CARBOXYL GROUP HAS BEEN REPLACED WITH THE BORONIC ACID GROUP (B(OH)2). CHAIN A RESIDUE NUMBERING IS DONE BY HOMOLOGY WITH CHYMOTRYPSIN FOR RESIDUES 15A - 245. CHAIN P INHIBITOR NUMBERING IS DONE BY ANALOGY TO PROTEASE SUBSTRATE NOMENCLATURE IN WHICH THE RESIDUE PRIOR TO THE SCISSILE BOND IS THE P1 RESIDUE, THE NEXT TOWARD THE N-TERMINUS IS THE P2 RESIDUE, ETC. Inhibitor METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID Peptide-like SO4 1 3 SO4 SO4 1 A SO4 2 3 SO4 SO4 2 A HOH 3 4 HOH HOH 246 A HOH 4 4 HOH HOH 247 A HOH 5 4 HOH HOH 248 A HOH 6 4 HOH HOH 249 A HOH 7 4 HOH HOH 250 A HOH 8 4 HOH HOH 251 A HOH 9 4 HOH HOH 252 A HOH 10 4 HOH HOH 253 A HOH 11 4 HOH HOH 254 A HOH 12 4 HOH HOH 255 A HOH 13 4 HOH HOH 256 A HOH 14 4 HOH HOH 257 A HOH 15 4 HOH HOH 258 A HOH 16 4 HOH HOH 259 A HOH 17 4 HOH HOH 260 A HOH 18 4 HOH HOH 261 A HOH 19 4 HOH HOH 262 A HOH 20 4 HOH HOH 263 A HOH 21 4 HOH HOH 264 A HOH 22 4 HOH HOH 265 A HOH 23 4 HOH HOH 266 A HOH 24 4 HOH HOH 267 A HOH 25 4 HOH HOH 268 A HOH 26 4 HOH HOH 269 A HOH 27 4 HOH HOH 270 A HOH 28 4 HOH HOH 271 A HOH 29 4 HOH HOH 272 A HOH 30 4 HOH HOH 273 A HOH 31 4 HOH HOH 274 A HOH 32 4 HOH HOH 275 A HOH 33 4 HOH HOH 276 A HOH 34 4 HOH HOH 277 A HOH 35 4 HOH HOH 278 A HOH 36 4 HOH HOH 279 A HOH 37 4 HOH HOH 280 A HOH 38 4 HOH HOH 281 A HOH 39 4 HOH HOH 282 A HOH 40 4 HOH HOH 283 A HOH 41 4 HOH HOH 284 A HOH 42 4 HOH HOH 285 A HOH 43 4 HOH HOH 286 A HOH 44 4 HOH HOH 287 A HOH 45 4 HOH HOH 288 A HOH 46 4 HOH HOH 289 A HOH 47 4 HOH HOH 290 A HOH 48 4 HOH HOH 291 A HOH 49 4 HOH HOH 292 A HOH 50 4 HOH HOH 293 A HOH 51 4 HOH HOH 294 A HOH 52 4 HOH HOH 295 A HOH 53 4 HOH HOH 296 A HOH 54 4 HOH HOH 297 A HOH 55 4 HOH HOH 298 A HOH 56 4 HOH HOH 299 A HOH 57 4 HOH HOH 300 A HOH 58 4 HOH HOH 301 A HOH 59 4 HOH HOH 302 A HOH 60 4 HOH HOH 303 A HOH 61 4 HOH HOH 304 A HOH 62 4 HOH HOH 305 A HOH 63 4 HOH HOH 306 A HOH 64 4 HOH HOH 307 A HOH 65 4 HOH HOH 308 A HOH 66 4 HOH HOH 309 A HOH 67 4 HOH HOH 310 A HOH 68 4 HOH HOH 311 A HOH 69 4 HOH HOH 312 A HOH 70 4 HOH HOH 313 A HOH 71 4 HOH HOH 314 A HOH 72 4 HOH HOH 315 A HOH 73 4 HOH HOH 316 A HOH 74 4 HOH HOH 317 A HOH 75 4 HOH HOH 318 A HOH 76 4 HOH HOH 319 A HOH 77 4 HOH HOH 320 A HOH 78 4 HOH HOH 321 A HOH 79 4 HOH HOH 322 A HOH 80 4 HOH HOH 323 A HOH 81 4 HOH HOH 324 A HOH 82 4 HOH HOH 325 A HOH 83 4 HOH HOH 326 A HOH 84 4 HOH HOH 327 A HOH 85 4 HOH HOH 328 A HOH 86 4 HOH HOH 329 A HOH 87 4 HOH HOH 330 A HOH 88 4 HOH HOH 331 A HOH 89 4 HOH HOH 332 A HOH 90 4 HOH HOH 333 A HOH 91 4 HOH HOH 334 A HOH 92 4 HOH HOH 335 A HOH 93 4 HOH HOH 336 A HOH 94 4 HOH HOH 337 A HOH 95 4 HOH HOH 338 A HOH 96 4 HOH HOH 339 A HOH 97 4 HOH HOH 340 A HOH 98 4 HOH HOH 341 A HOH 99 4 HOH HOH 342 A HOH 100 4 HOH HOH 343 A HOH 101 4 HOH HOH 344 A HOH 102 4 HOH HOH 345 A HOH 103 4 HOH HOH 346 A HOH 104 4 HOH HOH 347 A HOH 105 4 HOH HOH 348 A HOH 106 4 HOH HOH 349 A HOH 107 4 HOH HOH 350 A HOH 108 4 HOH HOH 351 A HOH 109 4 HOH HOH 352 A HOH 110 4 HOH HOH 353 A HOH 111 4 HOH HOH 354 A HOH 112 4 HOH HOH 355 A HOH 113 4 HOH HOH 356 A HOH 114 4 HOH HOH 357 A HOH 115 4 HOH HOH 358 A HOH 116 4 HOH HOH 359 A HOH 117 4 HOH HOH 360 A HOH 118 4 HOH HOH 361 A HOH 119 4 HOH HOH 362 A HOH 120 4 HOH HOH 363 A HOH 121 4 HOH HOH 364 A HOH 122 4 HOH HOH 365 A HOH 123 4 HOH HOH 366 A HOH 124 4 HOH HOH 367 A HOH 125 4 HOH HOH 368 A HOH 126 4 HOH HOH 369 A HOH 127 4 HOH HOH 370 A HOH 128 4 HOH HOH 371 A HOH 129 4 HOH HOH 372 A HOH 130 4 HOH HOH 373 A HOH 131 4 HOH HOH 374 A HOH 132 4 HOH HOH 375 A HOH 133 4 HOH HOH 376 A HOH 134 4 HOH HOH 377 A HOH 135 4 HOH HOH 378 A HOH 136 4 HOH HOH 379 A HOH 137 4 HOH HOH 380 A HOH 138 4 HOH HOH 381 A HOH 139 4 HOH HOH 382 A HOH 140 4 HOH HOH 383 A HOH 141 4 HOH HOH 384 A ALA 15 n 1 A ALA 15 A ASN 15 n 2 B ASN 15 A ILE 16 n 3 ILE 16 A VAL 17 n 4 VAL 17 A GLY 18 n 5 GLY 18 A GLY 19 n 6 GLY 19 A ILE 31 n 7 ILE 31 A GLU 32 n 8 GLU 32 A TYR 33 n 9 TYR 33 A SER 34 n 10 SER 34 A ILE 35 n 11 ILE 35 A ASN 36 n 12 ASN 36 A ASN 38 n 13 ASN 38 A ALA 39 n 14 ALA 39 A SER 40 n 15 SER 40 A LEU 41 n 16 LEU 41 A CYS 42 n 17 CYS 42 A SER 43 n 18 SER 43 A VAL 44 n 19 VAL 44 A GLY 44 n 20 A GLY 44 A PHE 45 n 21 PHE 45 A SER 46 n 22 SER 46 A VAL 47 n 23 VAL 47 A THR 48 n 24 THR 48 A ARG 48 n 25 A ARG 48 A GLY 48 n 26 B GLY 48 A ALA 48 n 27 C ALA 48 A THR 49 n 28 THR 49 A LYS 50 n 29 LYS 50 A GLY 51 n 30 GLY 51 A PHE 52 n 31 PHE 52 A VAL 53 n 32 VAL 53 A THR 54 n 33 THR 54 A ALA 55 n 34 ALA 55 A GLY 56 n 35 GLY 56 A HIS 57 n 36 HIS 57 A CYS 58 n 37 CYS 58 A GLY 59 n 38 GLY 59 A THR 59 n 39 A THR 59 A VAL 59 n 40 B VAL 59 A ASN 60 n 41 ASN 60 A ALA 61 n 42 ALA 61 A THR 62 n 43 THR 62 A ALA 64 n 44 ALA 64 A ARG 65 n 45 ARG 65 A ILE 66 n 46 ILE 66 A GLY 67 n 47 GLY 67 A GLY 81 n 48 GLY 81 A ALA 82 n 49 ALA 82 A VAL 83 n 50 VAL 83 A VAL 84 n 51 VAL 84 A GLY 85 n 52 GLY 85 A THR 87 n 53 THR 87 A PHE 88 n 54 PHE 88 A ALA 88 n 55 A ALA 88 A ALA 89 n 56 ALA 89 A ARG 90 n 57 ARG 90 A VAL 91 n 58 VAL 91 A PHE 94 n 59 PHE 94 A PRO 95 n 60 PRO 95 A GLY 100 n 61 GLY 100 A ASN 101 n 62 ASN 101 A ASP 102 n 63 ASP 102 A ARG 103 n 64 ARG 103 A ALA 104 n 65 ALA 104 A TRP 105 n 66 TRP 105 A VAL 106 n 67 VAL 106 A SER 107 n 68 SER 107 A LEU 108 n 69 LEU 108 A THR 109 n 70 THR 109 A SER 110 n 71 SER 110 A ALA 111 n 72 ALA 111 A GLN 112 n 73 GLN 112 A THR 113 n 74 THR 113 A LEU 114 n 75 LEU 114 A LEU 119 n 76 LEU 119 A PRO 120 n 77 PRO 120 A ARG 120 n 78 A ARG 120 A VAL 120 n 79 B VAL 120 A ALA 120 n 80 C ALA 120 A ASN 120 n 81 D ASN 120 A GLY 120 n 82 E GLY 120 A SER 120 n 83 G SER 120 A SER 120 n 84 H SER 120 A PHE 120 n 85 I PHE 120 A VAL 120 n 86 J VAL 120 A THR 120 n 87 K THR 120 A VAL 121 n 88 VAL 121 A ARG 122 n 89 ARG 122 A GLY 123 n 90 GLY 123 A SER 124 n 91 SER 124 A THR 125 n 92 THR 125 A GLU 129 n 93 GLU 129 A ALA 130 n 94 ALA 130 A ALA 131 n 95 ALA 131 A VAL 132 n 96 VAL 132 A GLY 133 n 97 GLY 133 A ALA 134 n 98 ALA 134 A ALA 135 n 99 ALA 135 A VAL 136 n 100 VAL 136 A CYS 137 n 101 CYS 137 A ARG 138 n 102 ARG 138 A SER 139 n 103 SER 139 A GLY 140 n 104 GLY 140 A ARG 141 n 105 ARG 141 A THR 142 n 106 THR 142 A THR 143 n 107 THR 143 A GLY 156 n 108 GLY 156 A TYR 157 n 109 TYR 157 A GLN 158 n 110 GLN 158 A CYS 159 n 111 CYS 159 A GLY 160 n 112 GLY 160 A THR 161 n 113 THR 161 A ILE 162 n 114 ILE 162 A THR 163 n 115 THR 163 A ALA 164 n 116 ALA 164 A LYS 165 n 117 LYS 165 A ASN 166 n 118 ASN 166 A VAL 167 n 119 VAL 167 A THR 168 n 120 THR 168 A ALA 169 n 121 ALA 169 A ASN 170 n 122 ASN 170 A TYR 171 n 123 TYR 171 A ALA 173 n 124 ALA 173 A GLU 174 n 125 GLU 174 A GLY 175 n 126 GLY 175 A ALA 176 n 127 ALA 176 A VAL 177 n 128 VAL 177 A ARG 178 n 129 ARG 178 A GLY 179 n 130 GLY 179 A LEU 180 n 131 LEU 180 A THR 181 n 132 THR 181 A GLN 182 n 133 GLN 182 A GLY 183 n 134 GLY 183 A ASN 184 n 135 ASN 184 A ALA 185 n 136 ALA 185 A CYS 189 n 137 CYS 189 A ALA 190 n 138 ALA 190 A GLY 191 n 139 GLY 191 A ARG 192 n 140 ARG 192 A GLY 193 n 141 GLY 193 A ASP 194 n 142 ASP 194 A SER 195 n 143 SER 195 A GLY 196 n 144 GLY 196 A GLY 197 n 145 GLY 197 A SER 198 n 146 SER 198 A TRP 199 n 147 TRP 199 A ILE 200 n 148 ILE 200 A THR 201 n 149 THR 201 A SER 201 n 150 A SER 201 A ALA 202 n 151 ALA 202 A GLY 207 n 152 GLY 207 A GLN 208 n 153 GLN 208 A ALA 209 n 154 ALA 209 A GLN 210 n 155 GLN 210 A GLY 211 n 156 GLY 211 A VAL 212 n 157 VAL 212 A MET 213 n 158 MET 213 A SER 214 n 159 SER 214 A GLY 215 n 160 GLY 215 A GLY 216 n 161 GLY 216 A ASN 217 n 162 ASN 217 A VAL 218 n 163 VAL 218 A GLN 219 n 164 GLN 219 A SER 219 n 165 A SER 219 A ASN 219 n 166 B ASN 219 A GLY 219 n 167 C GLY 219 A ASN 219 n 168 D ASN 219 A ASN 220 n 169 ASN 220 A CYS 220 n 170 A CYS 220 A GLY 221 n 171 GLY 221 A ILE 222 n 172 ILE 222 A PRO 222 n 173 A PRO 222 A ALA 222 n 174 B ALA 222 A SER 222 n 175 C SER 222 A GLN 223 n 176 GLN 223 A ARG 224 n 177 ARG 224 A SER 225 n 178 SER 225 A SER 226 n 179 SER 226 A LEU 227 n 180 LEU 227 A PHE 228 n 181 PHE 228 A GLU 229 n 182 GLU 229 A ARG 230 n 183 ARG 230 A LEU 231 n 184 LEU 231 A GLN 232 n 185 GLN 232 A PRO 233 n 186 PRO 233 A ILE 234 n 187 ILE 234 A LEU 235 n 188 LEU 235 A SER 236 n 189 SER 236 A GLN 237 n 190 GLN 237 A TYR 238 n 191 TYR 238 A GLY 239 n 192 GLY 239 A LEU 240 n 193 LEU 240 A SER 241 n 194 SER 241 A LEU 242 n 195 LEU 242 A VAL 243 n 196 VAL 243 A THR 244 n 197 THR 244 A GLY 245 n 198 GLY 245 A n 1 5 P ALA 4 n 2 ALA 4 P ALA 3 n 3 ALA 3 P PRO 2 n 4 PRO 2 P B2A 1 n 5 B2A 1 P author_and_software_defined_assembly PISA 2 dimeric 1060 -21 7860 P B2A 1 ALANINE BORONIC ACID B B2A 5 ALA 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O TYR 33 A O TYR 9 A N CYS 42 A N CYS 17 A O PHE 45 A O PHE 21 A N VAL 53 A N VAL 32 A O PHE 52 A O PHE 31 A N VAL 106 A N VAL 67 A O ARG 103 A O ARG 64 A N VAL 91 A N VAL 58 A O ALA 82 A O ALA 49 A N ILE 66 A N ILE 46 B A O VAL 120 A O VAL 79 J A N VAL 120 A N VAL 86 A O VAL 136 A O VAL 100 A N GLY 160 A N GLY 112 A O ALA 169 A O ALA 121 A N VAL 177 A N VAL 128 A O THR 181 A O THR 132 A N PHE 228 A N PHE 181 A O LEU 227 A O LEU 180 A N GLY 215 A N GLY 160 A O GLN 210 A O GLN 155 A N TRP 199 A N TRP 147 1 P MSU 5 B MSU 1 1 Y A A A 1 -5.26 0.50 120.30 115.04 A A A NE CZ NH2 ARG ARG ARG 48 48 48 N 1 3.97 0.50 120.30 124.27 A A A NE CZ NH1 ARG ARG ARG 65 65 65 N 1 4.44 0.50 120.30 124.74 A A A NE CZ NH1 ARG ARG ARG 90 90 90 N 1 6.66 0.80 106.30 112.96 A A A CD1 CG CD2 TRP TRP TRP 105 105 105 N 1 -5.89 0.80 107.30 101.41 A A A CE2 CD2 CG TRP TRP TRP 105 105 105 N A A A 1 3.06 0.50 120.30 123.36 A A A NE CZ NH1 ARG ARG ARG 120 120 120 N 1 -13.04 2.10 111.80 98.76 A A A CG CD NE ARG ARG ARG 122 122 122 N 1 7.21 0.50 120.30 127.51 A A A NE CZ NH1 ARG ARG ARG 122 122 122 N 1 -7.61 0.50 120.30 112.69 A A A NE CZ NH2 ARG ARG ARG 122 122 122 N 1 -3.14 0.50 120.30 117.16 A A A NE CZ NH2 ARG ARG ARG 178 178 178 N 1 6.29 0.80 106.30 112.59 A A A CD1 CG CD2 TRP TRP TRP 199 199 199 N 1 -5.56 0.80 107.30 101.74 A A A CE2 CD2 CG TRP TRP TRP 199 199 199 N 1 A A NE2 CD2 HIS HIS 57 57 -0.067 0.011 1.373 1.306 N 1 A ALA 39 -138.85 -80.19 1 A PRO 95 -76.14 -159.54 1 A PRO 120 -82.54 49.32 1 A SER 214 -103.79 -62.32 THE METHOXYSUCCINYL PORTION OF THE INHIBITOR WAS DISORDERED AND NO COORDINATES ARE INCLUDED FOR IT IN THIS ENTRY 0.134 0.134 2.13 17.5 11560 1 2.0 2.13 17.5 139 1560 10 0 1411 0.014 2.6 25.9 1.26 2.13 17.5 1GBK 11778 1 82.0 data collection RIGAKU AFC5 CONTROL SOFTWARE model building X-PLOR 3.1 refinement X-PLOR 3.1 data reduction RIGAKU AFC5 CONTROL SOFTWARE phasing X-PLOR 3.1 ALPHA-LYTIC PROTEASE, METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID 1 N N 2 N N 3 N N 3 N N 4 N N A GLY 56 A GLY 35 HELX_P A CYS 58 A CYS 37 5 1 3 A ALA 222 A ALA 174 HELX_P A GLN 223 A GLN 176 5 2 3 B A LEU 231 A LEU 184 HELX_P A TYR 238 A TYR 191 1 3 8 disulf 2.036 A CYS 42 A SG CYS 17 1_555 A CYS 58 A SG CYS 37 1_555 disulf 2.014 A CYS 137 A SG CYS 101 1_555 A CYS 159 A SG CYS 111 1_555 disulf 2.007 A A CYS 189 A SG CYS 137 1_555 A CYS 220 A SG CYS 170 1_555 covale 1.333 P B2A 1 B N B2A 5 1_555 P PRO 2 B C PRO 4 1_555 covale 1.381 P B2A 1 B B B2A 5 1_555 A SER 195 A OG SER 143 1_555 HYDROLASE/HYDROLASE INHIBITOR ACTIVE-SITE MUTATION, SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX A PHE 94 A PHE 59 1 A PRO 95 A PRO 60 -11.18 PRLA_LYSEN UNP 1 1 P00778 MYVSNHRSRRVARVSVSCLVAALAAMSCGAALAADQVDPQLKFAMQRDLGIFPTQLPQYLQTEKLARTQAAAIEREFGAQ FAGSWIERNEDGSFKLVAATSGARKSSTLGGVEVRNVRYSLKQLQSAMEQLDAGANARVKGVSKPLDGVQSWYVDPRSNA VVVKVDDGATEAGVDFVALSGADSAQVRIESSPGKLQTTANIVGGIEYSINNASLCSVGFSVTRGATKGFVTAGHCGTVN ATARIGGAVVGTFAARVFPGNDRAWVSLTSAQTLLPRVANGSSFVTVRGSTEAAVGAAVCRSGRTTGYQCGTITAKNVTA NYAEGAVRGLTQGNACMGRGDSGGSWITSAGQAQGVMSGGNVQSNGNNCGIPASQRSSLFERLQPILSQYGLSLVTG 1GBK PDB 2 1 1GBK (MSU)AAP(B2A) 200 397 1GBK 15 245 P00778 A A 1 1 198 5 1 1GBK 1 5 1GBK P 2 5 1 1 MET ENGINEERED MUTATION ALA 190 1GBK A P00778 UNP 337 138 2 5 2 2 2 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLU 32 A GLU 8 A ILE 35 A ILE 11 A SER 40 A SER 15 A SER 43 A SER 18 A PHE 45 A PHE 21 A ARG 48 A ARG 25 A A THR 49 A THR 28 A THR 54 A THR 33 A ARG 103 A ARG 64 A LEU 108 A LEU 69 A ALA 82 A ALA 49 A VAL 91 A VAL 58 A THR 62 A THR 43 A ILE 66 A ILE 46 A ARG 120 A ARG 78 A ASN 120 A ASN 81 A D A SER 120 A SER 84 A THR 120 A THR 87 H K A ALA 135 A ALA 99 A GLY 140 A GLY 104 A GLY 156 A GLY 108 A THR 161 A THR 113 A ALA 169 A ALA 121 A TYR 171 A TYR 123 A GLY 175 A GLY 126 A VAL 177 A VAL 128 A THR 181 A THR 132 A GLY 183 A GLY 134 A SER 226 A SER 179 A ARG 230 A ARG 183 A ALA 209 A ALA 154 A GLY 216 A GLY 161 A SER 198 A SER 146 A ILE 200 A ILE 148 BINDING SITE FOR RESIDUE SO4 A 1 Software 7 BINDING SITE FOR RESIDUE SO4 A 2 Software 6 BINDING SITE FOR CHAIN P OF METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID INHIBITOR Software 10 A SER 120 A SER 83 G 7 4_555 A GLY 123 A GLY 90 7 5_565 A SER 124 A SER 91 7 5_565 A THR 125 A THR 92 7 5_565 A ARG 192 A ARG 140 7 1_555 A HOH 254 E HOH 7 5_565 A HOH 294 E HOH 7 5_565 A ALA 15 A ALA 1 A 6 3_665 A ASN 15 A ASN 2 B 6 3_665 A ARG 230 A ARG 183 6 1_555 A PRO 233 A PRO 186 6 1_555 A HOH 270 E HOH 6 3_665 A HOH 366 E HOH 6 3_665 A HIS 57 A HIS 36 10 1_555 A ARG 122 A ARG 89 10 5_565 A TYR 171 A TYR 123 10 1_555 A GLY 193 A GLY 141 10 1_555 A ASP 194 A ASP 142 10 1_555 A SER 195 A SER 143 10 1_555 A SER 214 A SER 159 10 1_555 A GLY 215 A GLY 160 10 1_555 A GLY 216 A GLY 161 10 1_555 A HOH 355 E HOH 10 5_565 154 P 32 2 1